SKBI [SKYSTAR BIO-PHARMACEUTICAL] 10-Q/A: Explanatory Note No. 31.1 * 31.2 * 32.1

[Explanatory Note No. 31.1 * 31.2 * 32.1 * 32.2 * 101.INS** XBRL Instance Document 101.SCH** XBRL Taxonomy Extensionhema Document 101.CAL** XBRL Taxonomy Extensionlculation Linkbase Document 101.DEF** XBRL Taxonomy Extension Definition Linkbase Document 101.LAB** XBRL Taxonomy Extension Labels Linkbase Document 101.PRE** XBRL Taxonomy Extension Presentation Linkbase DocumentYSTARBIO-PHARMACEUTICALCOMPANY September 13, 2012]

By | 2016-02-05T03:08:43+00:00 September 13th, 2012|Categories: Chinese Stocks, SKBI, Webplus ver|Tags: , , , , , |0 Comments

SKBI [SKYSTAR BIO-PHARMACEUTICAL CO] 10-Q: (Original Filing)

[] [SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002 I, Weibing Lu, certify that: 1. I have reviewed this quarterly report on Form 10-Q of Skystar Bio-Pharmaceutical Company; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of] [SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002 I, Bing Mei, certify that: 1. I have reviewed this quarterly report on Form 10-Q of Skystar Bio-Pharmaceutical Company; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of] [(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. Weibing Lu, Chief Executive Officer] [(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. Bing Mei, Chief Financial Officer]

By | 2016-03-01T04:35:33+00:00 August 14th, 2012|Categories: Chinese Stocks, SEC Original, SKBI|Tags: , , , , , |0 Comments

SKBI [SKYSTAR BIO-PHARMACEUTICAL CO] 10-Q:

[] [SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002 I, Weibing Lu, certify that: 1. I have reviewed this quarterly report on Form 10-Q of Skystar Bio-Pharmaceutical Company; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of] [SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002 I, Bing Mei, certify that: 1. I have reviewed this quarterly report on Form 10-Q of Skystar Bio-Pharmaceutical Company; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of] [(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. Weibing Lu, Chief Executive Officer] [(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. Bing Mei, Chief Financial Officer]

By | 2016-03-01T04:36:37+00:00 August 14th, 2012|Categories: Chinese Stocks, SKBI, Webplus ver|Tags: , , , , , |0 Comments

SKBI [SKYSTAR BIO-PHARMACEUTICAL] 10-Q: (Original Filing)

[SKYSTAR BIO-PHARMACEUTICALMPANY FORM10-Q INDEX Page No. PART I.FINANCIAL INFORMATION 4 Item 1.ndensednsolidated Financial Statements 4ndensednsolidated Balance Sheets of June 30, 2012 (unaudited) and December 31, 2011 4ndensednsolidated Statements ofome andmprehensiveome for the Three Months and Six Months Ended June 30, 2012 and 2011 (unaudited)] [SECTION 302 OF THERBANES-OXLEY ACT OF 2002 I, Weibing Lu, certify that: 1. I have reviewed this quarterly report on Form 10-Q ofystar Bio-Pharmaceuticalmpany; 2. Based on my knowledge, this report does notntain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light] [SECTION 302 OF THERBANES-OXLEY ACT OF 2002 I, Bing Mei, certify that: 1. I have reviewed this quarterly report on Form 10-Q ofystar Bio-Pharmaceuticalmpany; 2. Based on my knowledge, this report does notntain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light] [(2)The informationntained in the Report fairly presents, inl material respects, the financialndition and results of operations of thempany. Weibing Lu, Chief Executive Officer v319792_ex32-1.htm 5 EX-32.1] [(2) The informationntained in the Report fairly presents, inl material respects, the financialndition and results of operations of thempany. Bing Mei, Chief Financial Officer v319792_ex32-2.htm 6 EX-32.2]

By | 2016-02-05T03:10:02+00:00 August 14th, 2012|Categories: Chinese Stocks, SEC Original, SKBI|Tags: , , , , , |0 Comments

SKBI [SKYSTAR BIO-PHARMACEUTICAL CO] 8-K: (Original Filing)

[Crowe Horwath LLP Independent Member Crowe Horwath International July 6, 2012 Office of the Chief Accountant 100 F Street, N.E. Ladies and Gentlemen: We have read the comments made regarding us in Item 4.01 of Form 8-K of Skystar Bio-Pharmaceutical Company, dated June 29, 2012 and filed July 6, 2012, as contained in the first, second, and third paragraphs of]

By | 2016-03-01T04:38:24+00:00 July 6th, 2012|Categories: Chinese Stocks, SEC Original, SKBI|Tags: , , , , , |0 Comments

SKBI [SKYSTAR BIO-PHARMACEUTICAL CO] 8-K: Crowe Horwath LLP Independent Member Crowe Horwath International

[Crowe Horwath LLP Independent Member Crowe Horwath International July 6, 2012 Office of the Chief Accountant 100 F Street, N.E. Ladies and Gentlemen: We have read the comments made regarding us in Item 4.01 of Form 8-K of Skystar Bio-Pharmaceutical Company, dated June 29, 2012 and filed July 6, 2012, as contained in the first, second, and third paragraphs of]

By | 2016-03-01T04:40:03+00:00 July 6th, 2012|Categories: Chinese Stocks, SKBI, Webplus ver|Tags: , , , , , |0 Comments

SKBI [SKYSTAR BIO-PHARMACEUTICAL] 8-K: (Original Filing)

[Crowe Horwath Independent Member Crowe Horwath International July 6, 2012 Office of the Chief Accountant 100 F Street, N.E. Ladies and Gentlemen: We have read themments made regarding us in Item 4.01 of Form 8-K ofystar Bio-Pharmaceuticalmpany,ted June 29, 2012 and filed July 6, 2012,ntained in the first, second, and third paragraphs of Item 4.01]

By | 2016-02-05T03:12:05+00:00 July 6th, 2012|Categories: Chinese Stocks, SEC Original, SKBI|Tags: , , , , , |0 Comments

SKBI [SKYSTAR BIO-PHARMACEUTICAL] 8-K: Crowe Horwath Independent Member Crowe Horwath International July

[Crowe Horwath Independent Member Crowe Horwath International July 6, 2012 Office of the Chief Accountant 100 F Street, N.E. Ladies and Gentlemen: We have read themments made regarding us in Item 4.01 of Form 8-K ofystar Bio-Pharmaceuticalmpany,ted June 29, 2012 and filed July 6, 2012,ntained in the first, second, and third paragraphs of Item 4.01]

By | 2016-02-05T03:12:36+00:00 July 6th, 2012|Categories: Chinese Stocks, SKBI, Webplus ver|Tags: , , , , , |0 Comments

SKBI [SKYSTAR BIO-PHARMACEUTICAL CO] 10-Q: (Original Filing)

[] [SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002 I, Weibing Lu, certify that: 1. I have reviewed this quarterly report on Form 10-Q of Skystar Bio-Pharmaceutical Company; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of] [SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002 I, Bing Mei, certify that: 1. I have reviewed this quarterly report on Form 10-Q of Skystar Bio-Pharmaceutical Company; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (2) The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company at the dates and for the periods indicated. Weibing Lu Chief Executive Officer May 15, 2012] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (2) The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company at the dates and for the periods indicated. Bing Mei Chief Financial Officer May 15, 2012]

By | 2016-03-01T04:42:14+00:00 May 15th, 2012|Categories: Chinese Stocks, SEC Original, SKBI|Tags: , , , , , |0 Comments

SKBI [SKYSTAR BIO-PHARMACEUTICAL CO] 10-Q:

[] [SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002 I, Weibing Lu, certify that: 1. I have reviewed this quarterly report on Form 10-Q of Skystar Bio-Pharmaceutical Company; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of] [SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002 I, Bing Mei, certify that: 1. I have reviewed this quarterly report on Form 10-Q of Skystar Bio-Pharmaceutical Company; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (2) The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company at the dates and for the periods indicated. Weibing Lu Chief Executive Officer May 15, 2012] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (2) The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company at the dates and for the periods indicated. Bing Mei Chief Financial Officer May 15, 2012]

By | 2016-03-01T04:43:50+00:00 May 15th, 2012|Categories: Chinese Stocks, SKBI, Webplus ver|Tags: , , , , , |0 Comments
Skip to toolbar